These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8266011)

  • 1. A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disorders.
    Collazos J; Genollá J; Ruibal A
    Scand J Clin Lab Invest; 1993 Oct; 53(6):633-7. PubMed ID: 8266011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory evaluation of CA 19-9 in cirrhotic patients.
    Collazos J
    Eur J Med; 1992; 1(4):215-8. PubMed ID: 1341447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of CA 50 in nonmalignant liver diseases: a clinical and biochemical study.
    Collazos J; Genolla J; Ruibal A
    Am J Gastroenterol; 1993 Mar; 88(3):409-12. PubMed ID: 8438849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tissue polypeptide antigen as a biological marker of malignant pleural mesothelioma].
    Tokuyama T; Okamoto Y; Hamada K; Yoneda T; Narita N; Tamura M; Kitamura K; Maruyama H; Takezawa Y; Yamada Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):609-15. PubMed ID: 9294293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosis.
    Collazos J; Genollá J; Ruibal A
    Digestion; 1992; 53(3-4):157-61. PubMed ID: 1291404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases.
    Gonzalez-Quintela A; Mallo N; Mella C; Campos J; Perez LF; Lopez-Rodriguez R; Tome S; Otero E
    Liver Int; 2006 Dec; 26(10):1217-24. PubMed ID: 17105587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum tissue polypeptide antigen in the detection of hepatocellular carcinoma in cirrhotic patients.
    Leandro G; Zizzari S; Piccoli A; Manghisi OG
    Hepatogastroenterology; 1990 Oct; 37(5):449-51. PubMed ID: 2174822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of tissue polypeptide specific antigen as a marker in liver diseases.
    Cetin T; Oğuz A; Algan P; Yildirim IS
    Turk J Gastroenterol; 2003 Sep; 14(3):177-80. PubMed ID: 14655061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
    Sakahara H; Endo K; Torizuka K; Itoh K; Ohuchi N; Inaba N; Miyaji Y; Takayama M; Ishii K; Takagi H; Konishi J; Fukuoka M; Fukuchi M; Ohkawa J; Kagawa S; Kondo S; Shirouzu K; Iguchi H
    Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders.
    Gallo V; Cerutti E; Riberi A; Re M; Petrino R; Pecchio F
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):89-93. PubMed ID: 2480432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer.
    van Poppel H; Billen J; Goethuys H; Elgamal AA; Gerits M; Mortelmans L; Blanckaert N; Baert L
    Anticancer Res; 1996; 16(4B):2205-7. PubMed ID: 8694544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker].
    Kanauchi M; Sawai F; Saito T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1984 Mar; 30(3):265-71. PubMed ID: 6201629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue polypeptide antigen (TPA) in chronic active hepatitis and mild liver diseases.
    Collazos J; Genollà J; Ruibal A
    Int J Biol Markers; 1992; 7(4):249-52. PubMed ID: 1491182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of TPA-assay kit using monoclonal antibodies].
    Saga T; Sakahara H; Kousaka T; Yao Z; Nakamoto Y; Hattori N; Zhang M; Nakayama M; Ohshio G; Imamura M; Konishi J
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):615-21. PubMed ID: 8678521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH; Lenk SV; Schlechte HH; Loening SA
    Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical value of tissue polypeptide antigen in ovarian carcinoma].
    Wu L; Sun J; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis.
    Haukeland JW; Schreiner LT; Lorgen I; Frigstad SO; Bang C; Raknerud N; Konopski Z
    Scand J Gastroenterol; 2008; 43(10):1241-8. PubMed ID: 18609128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diaphragmatic cyst with elevated level of serum tissue polypeptide antigen.
    Ueda H; Andoh K; Kusano T; Iwasaki A; Inutsuka S
    Thorac Cardiovasc Surg; 1992 Aug; 40(4):195-7. PubMed ID: 1412392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia.
    Tramonti G; Ferdeghini M; Donadio C; Norpoth M; Annichiarico C; Bianchi R; Bianchi C
    Cancer Detect Prev; 2000; 24(1):86-90. PubMed ID: 10757127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.